Other versions:

(Verbatim name)

ID

(Catalog Number)

ORG

DES

Invalid DOI was provided, please try again

XML
PDF
 
 
Twitter
Facebook
Mendeley
Reddit
Notify a colleague
  • ContentsContents
  • Article InfoArticle Info
  • CiteCite
  • MetricsMetrics
  • CommentComment
  • RelatedRelated
  • FigsFigs
  • TabsTabs
  • RefsRefs
  • CitedCited
  • Article title
  • Abstract
  • Keywords
  • Introduction
  • Methods
  • Results and discussions
    • Assessment of the availability and accessibility of TKIs for the treatment of CML in Bulgaria
    • Economic analysis of CML treatment costs at the national level for the period 2018–2022
    • Evaluation of the costs of the treatment of patients with CML and of the achieved molecular response as an indicator of the effectiveness of the therapy in the hematology clinic at UMHAT„St. George“ at the MU-Plovdiv
    • Pharmacoeconomic analyses of the cost-effectiveness of TKI therapies in the first- and second- lines of treatment for patients with CML-CP
      • A comparative evaluation of the cost-effectiveness of individual TKI therapies for the treatment of patients with CML-CP on first- and second- line therapy using the Decision Analysis method
  • Conclusion
  • Author Contributions
  • Funding
  • Institutional review board statement
  • Informed consent statement
  • Data availability statement
  • References
Subscribe to email alerts for current Article's categories
Powered by